Hospital costs associated with adverse events in people with diabetes in the UK
<p><strong>Aims:</strong> Robust cost estimates are required to inform economic analysis of diabetes treatments. We estimate the annual hospital costs associated with a range of adverse events for people with diabetes in the UK.</p> <p><strong>Methods:</strong...
Main Authors: | Keng, MJ, Leal, J, Armitage, J, Bowman, L, Mihaylova, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2022
|
Similar Items
-
Decrements in health‐related quality of life associated with adverse events in people with diabetes
by: Keng, MJ, et al.
Published: (2021) -
Performance of the UKPDS Outcomes Model 2 in a contemporary UK type 2 diabetes trial cohort
by: Keng, MJ, et al.
Published: (2021) -
Impact of new cardiovascular events on quality of life and hospital costs in people with cardiovascular disease in the United Kingdom and United States
by: Lui, JNM, et al.
Published: (2023) -
Prediction models for individual-level healthcare costs associated with cardiovascular events in the UK
by: Zhou, J, et al.
Published: (2023) -
The effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
by: Kent, S, et al.
Published: (2016)